Sat.Nov 26, 2022 - Fri.Dec 02, 2022

article thumbnail

Steps to building a more patient-centric industry

Pharma Phorum

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials.

article thumbnail

FDA approves first microbiota-based treatment

Bio Pharma Dive

The regulatory OK, a milestone for microbiome-based drug research, is for a medicine from Ferring Pharma that treats a recurrent type of gut infection

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NHS expedites rollout of Bayer’s darolutamide for prostate cancer

Pharmaceutical Technology

The National Health Service (NHS) in England, UK, has expedited the rollout of Bayer ’s new life-extending drug, darolutamide, to treat the most advanced kinds of prostate cancer that have spread to other body parts.

Branding 241
article thumbnail

Botanical Solution Inc. (BSI) & Croda Pharma Partnership Agreement to Accelerate Production for GMP QS-21  

Pharma Mirror

QS-21 in blockbuster Shingles vaccine, first vaccine approved for Malaria, promising RSV phase III candidate, and Covid-19 applications. Botanical Solution Inc.

article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

article thumbnail

Get Set up for Success in the Account Incubator Program

Intouch Solutions

Finding an agency job after graduating college can feel overwhelming, but it doesn’t have to. Jumpstart your career at EVERSANA INTOUCH and be set up for success as part of our Account Incubator program where you can dip your toes into an Account Services role!

article thumbnail

What to make of Eisai and Biogen’s latest Alzheimer’s drug data

Bio Pharma Dive

At a medical conference, the companies detailed clinical trial results that could help support approval of their drug, lecanemab. However, some doctors aren’t yet convinced the medicine’s risks are worth its potential benefits

Doctors 282

More Trending

article thumbnail

Role of data in shaping the future of Healthcare AI

Pharma Mirror

As AI technology advances, it is quickly finding its way into the world of healthcare. The rise of machine learning and chatbots in healthcare is moving away from the traditionally doctor-centric model and towards a more patient-centric and automated process built on trust and data.

Doctors 130
article thumbnail

The European Commission and WHO extend their strategic cooperation to deliver better health for all

The Pharma Data

The European Commission and WHO extend their strategic cooperation to deliver better health for all.

article thumbnail

Sana reshuffles drug pipeline, becoming latest biotech to cut staff

Bio Pharma Dive

The richly funded drugmaker will cut 15% of its workforce, or about 75 employees, as well as stop work on one of its preclinical research programs

Research 270
article thumbnail

Expanding ketamine’s horizons to treat rare neurological disorders

Pharmaceutical Technology

For several decades, researchers have been investigating the role of ketamine in treating depression. Now, efforts are underway to study ketamine’s effects in Parkinson’s disease, fibromyalgia, and Rett syndrome.

article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

article thumbnail

Touchlight receives funding to develeop DNA vaccine platform

Pharma Times

Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA

DNA 111
article thumbnail

AMGEN TO WEBCAST INVESTOR CALL AT WCIRDC 2022

The Pharma Data

AMGEN TO WEBCAST INVESTOR CALL AT WCIRDC 2022. Amgen (NASDAQ: AMGN) will host a webcast call for the investment community in conjunction with the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) at 8:00 a.m. ET on Monday, Dec. 5, 2022. David M. Reese, M.D.,

Insulin 83
article thumbnail

Rigel wins US approval of rival drug to Servier leukemia treatment

Bio Pharma Dive

The approval gives Rigel, a biotech that’s been around since the mid-1990s, its second marketed medicine and a competitor to Servier’s Tibsovo

Marketing 255
article thumbnail

US FDA approves Ferring’s Rebyota for Clostridioides difficile infection

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Ferring Pharmaceuticals’ faecal microbiota product, Rebyota, to prevent Clostridioides difficile infection (CDI) recurrence in people aged 18 years and above.

article thumbnail

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

article thumbnail

Eisai and Biogen present promising lecanemab study results

Pharma Times

Phase 3 research shows that Alzheimer’s disease treatment meets primary and secondary endpoints

Research 110
article thumbnail

WHO recommends a new name for monkeypox disease

The Pharma Data

WHO recommends a new name for monkeypox disease. Following a series of consultations with global experts, WHO will begin using a new preferred term “mpox” as a synonym for monkeypox. Both names will be used simultaneously for one year while “monkeypox” is phased out.

82
article thumbnail

Pfizer, Roivant set up new company around inflammation drug

Bio Pharma Dive

The drug is currently in mid-stage testing as a treatment for ulcerative colitis. If it continues to advance, it could be the first approved therapy aimed at a protein known as TL1A, a target multiple other companies are pursuing

Protein 256
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries.

Hormones 219
article thumbnail

Healthcare leaders warn about unsustainable pressure on mental health services

Pharma Times

Patients and service users routinely struggle to access mental healthcare across the NHS

107
107
article thumbnail

With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker

Fierce Pharma

With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker. fkansteiner. Fri, 12/02/2022 - 09:51

Drugs 98
article thumbnail

FDA lifts pause on Beam plans to test base editing cancer therapy

Bio Pharma Dive

The FDA’s decision is a step forward for a type of drugmaking known as “multiplex editing,” which involves editing several genes simultaneously

Gene 250
article thumbnail

C4XD and AstraZeneca enter $402m deal to develop respiratory disease therapy

Pharmaceutical Technology

C4X Discovery (C4XD) and AstraZeneca have entered an exclusive global licensing agreement worth up to $402m to develop oral therapy to treat inflammatory and respiratory ailments. The deal has been signed to develop the C4X NRF2 Activator programme for these ailments.

article thumbnail

Immutep in clinical trail collaboration with Merck KGaA and Pfizer

Pharma Times

Research will focus on eftilagimod alpha and avelumab for the treatment of urothelial cancer

Research 108
article thumbnail

Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy

Fierce Pharma

Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy. ntaylor. Mon, 11/28/2022 - 10:11

Trials 97
article thumbnail

Spectrum to lay off R&D staff after FDA drug rejection

Bio Pharma Dive

The company will cut its R&D workforce by 75% and discontinue development of its experimental lung cancer drug poziotinib

article thumbnail

Current pipeline developments could bring new hope for patients with PPMS

Pharmaceutical Technology

Multiple sclerosis (MS) is an autoimmune disease causing chronic inflammation and demyelination of the nerves, affecting around 2.5 million people worldwide.

article thumbnail

C4XD signs NRF2 Activator deal with AstraZeneca

Pharma Times

C4XD will receive milestone payments worth up to $16m ahead of the first clinical trial

article thumbnail

With FDA nod for its fecal microbiome therapy, Ferring becomes No. 1 in No. 2

Fierce Pharma

With FDA nod for its fecal microbiome therapy, Ferring becomes No. 1 in No. kdunleavy. Thu, 12/01/2022 - 10:14

94
article thumbnail

Gene editing startup iECURE returns to investors for fresh funding

Bio Pharma Dive

The company, which draws on research by Jim Wilson’s lab at UPenn, says the $65 million it raised will support the start of human testing of its lead drug through to initial clinical data

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries.

Hormones 207
article thumbnail

Respiratory vaccination candidate tested in German hospitals

Pharma Times

Novel tuberculosis vaccine tested in a large phase 3 trial against severe respiratory infection disease

Trials 106
article thumbnail

Second Circuit Decision A Reminder that Alleged FDCA violations don’t always equal FCA violations

The FDA Law Blog

By JP Ellison & Holly N.

article thumbnail

Mainstreaming cell and gene therapy – Realizing its potential

Bio Pharma Dive

The challenges biopharma companies face in running clinical trials and tips on how to surmount those obstacles

article thumbnail

How to cut drug supply costs with seamless forecasting and IRT systems

Pharmaceutical Technology

An accurate drug supply forecast is essential for a successful clinical trial. Without it, sponsors risk a shortage of investigative medicinal product (IMP) for patients, resulting in major trial delays.